HUNHuntsman CORP
Chemicals & Allied Products
- Revenue
- $5.7B
- 5.8% YoY
- Operating margin
- -2.3%
- 457% YoY
- EBITDA
- $156M
- 41% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- 10.8×
- $1.7B net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear—Cash flow under 80% of net income
- Dilutive SBCClear1% of revenueOver 10% of revenue
- Payouts exceed cash flowClear51% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear9% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $7.7B | $8.0B | $6.1B | $6.0B | $5.7B | 5.8% |
| Operating income | $731M | $672M | $84M | −$25M | −$131M | 424% |
| Net income | $1.0B | $460M | $101M | −$189M | −$284M | 50% |
| Operating cash flow | $952M | $914M | $209M | $263M | $289M | 9.9% |
| Capex | $326M | $272M | $230M | $184M | $173M | 6.0% |
| Stock-based comp | $30M | $29M | $28M | $30M | $31M | 3.3% |
| Buybacks | $200M | $1.0B | $349M | $4M | $0 | 100% |
| Dividends | $159M | $171M | $169M | $174M | $146M | 16% |
Deal filings
None.
13D filers
None on file.
Insider trading
No open-market trades in the last 12 months.
Pay vs performance
No pay-versus-performance disclosure yet.